| |
| |
|
| Insider
Information: |
Carter Paul Rutherford |
| Relationship: |
Director |
| City: |
Uxbridge, Middlesex |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,305 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,004,342 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,305 |
|
|
| Total
Value |
$4,004,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP Commercial Ops |
2016-08-01 |
62,305 |
2014-02-10 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2022-06-16 |
0 |
2018-05-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-08-26 |
4 |
S |
$106.16 |
$1,061,618 |
D/D |
(10,000) |
32,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-08-26 |
4 |
OE |
$19.09 |
$190,850 |
D/D |
10,000 |
42,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-09-26 |
4 |
OE |
$40.56 |
$81,120 |
D/D |
2,000 |
34,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-09-26 |
4 |
AS |
$107.47 |
$214,945 |
D/D |
(2,000) |
32,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-10-01 |
4 |
OE |
$40.56 |
$81,120 |
D/D |
2,000 |
34,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-10-01 |
4 |
AS |
$106.39 |
$212,785 |
D/D |
(2,000) |
32,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-10-24 |
4 |
OE |
$40.56 |
$81,120 |
D/D |
2,000 |
34,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-10-24 |
4 |
AS |
$110.00 |
$220,007 |
D/D |
(2,000) |
32,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-11-03 |
4 |
AS |
$112.46 |
$337,380 |
D/D |
(3,000) |
32,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-11-03 |
4 |
OE |
$40.56 |
$121,680 |
D/D |
3,000 |
35,244 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-11-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,800 |
37,044 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-11-04 |
4 |
A |
$109.72 |
$300,194 |
D/D |
2,736 |
34,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-12-01 |
4 |
OE |
$40.56 |
$81,120 |
D/D |
2,000 |
36,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-12-01 |
4 |
AS |
$100.02 |
$200,031 |
D/D |
(2,000) |
34,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-01-02 |
4 |
AS |
$95.05 |
$95,050 |
D/D |
(1,000) |
34,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-01-02 |
4 |
OE |
$40.56 |
$40,560 |
D/D |
1,000 |
35,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-01-08 |
4 |
OE |
$26.99 |
$36,720 |
D/D |
1,000 |
35,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-01-08 |
4 |
AS |
$100.88 |
$100,881 |
D/D |
(1,000) |
34,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-02-02 |
4 |
OE |
$80.65 |
$161,300 |
D/D |
2,000 |
36,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-02-02 |
4 |
AS |
$106.15 |
$212,310 |
D/D |
(2,000) |
34,308 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-02-13 |
4 |
A |
$85.61 |
$21,232 |
D/D |
248 |
34,556 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-02-17 |
4 |
D |
$103.84 |
$1,677,743 |
D/D |
(16,157) |
45,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
27,040 |
61,596 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-03-02 |
4 |
OE |
$80.65 |
$161,300 |
D/D |
2,000 |
47,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-03-02 |
4 |
AS |
$104.18 |
$208,364 |
D/D |
(2,000) |
45,439 |
0 |
- |
|
106 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
